Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 16/20 | 0.66 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.57 |
| ▸ | CD47 | Q08722 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12508010 | 0.95 | IL23R (0.66) | IL23RKISS1RCD47 | |
| SCHEMBL13248747 | 0.95 | IL23R (0.66) | IL23RKISS1RCD47 | |
| SCHEMBL12417333 | 0.95 | IL23R (0.66) | IL23RKISS1RCD47 | |
| SCHEMBL13248726 | 0.95 | KISS1R (0.66) | IL23RKISS1R | |
| SCHEMBL29403130 | 0.94 | IL23R (0.65) | IL23RKISS1RCD47 | |
| SCHEMBL7738071 | 0.94 | IL23R (0.66) | IL23RKISS1R | |
| SCHEMBL7731842 | 0.94 | IL23R (0.66) | IL23RKISS1R | |
| SCHEMBL12508017 | 0.94 | IL23R (0.66) | IL23RKISS1R | |
| SCHEMBL29403216 | 0.93 | IL23R (0.66) | IL23RKISS1R | |
| SCHEMBL14498050 | 0.92 | IL23R (0.64) | IL23RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100179093-A1 | Neoropeptide-2-Receptor (Y-2R) Agonists | DANHO WALEED | 2010-07-15 | — | — | US | disclosed |
| US-20100179093-A1 | Neoropeptide-2-Receptor (Y-2R) Agonists | DANHO WALEED | 2010-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179093-A1 | Neoropeptide-2-Receptor (Y-2R) Agonists | NPY2R, NPY1R, NPY4R | IL23R 392/4885KISS1R 147/4885CD47 2998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.